Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
4.460
0.00 (0.00%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Lifecore Biomedical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Lifecore Biomedical stock has a consensus rating of "Buy" and an average price target of $6.75. The average 1-year stock price forecast is 51.35% higher than the current stock price, while the lowest is $5.00 (+12.11%) and the highest is $9.00 (+101.79%).
Price Target: $6.75 (+51.35%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Lifecore Biomedical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington | Barrington | Buy Maintains $6.25 | Buy | Maintains | $6.25 | +40.13% | Sep 3, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 11, 2026 |
| KeyBanc | KeyBanc | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 6, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 6, 2026 |
Financial Forecast
Revenue This Year
121.53M
from 128.87M
Decreased by -6.13%
Revenue Next Year
130.61M
from 121.53M
Increased by 7.47%
EPS This Year
-0.88
from -0.43
EPS Next Year
-0.78
from -0.88
EPS and Forward PE are based on non-GAAP adjusted numbers.